Earnings Feed
Start Free
Home/Filings/4/0001437749-17-006971
4//SEC Filing

Oxford Immunotec Global PLC 4

Accession 0001437749-17-006971

CIK 0001586049operating
View on SEC.govCompany Profile

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 4:30 PM ET

Size

13.4 KB

Accession

0001437749-17-006971

Insider Transaction Report

Form 4
Period: 2017-04-21
Oxford Immunotec Global PLCOXFD
Edwardson Peter
Chief Operations Officer
Transactions
  • Exercise/Conversion

    Share Option (Right to Buy)

    2017-04-21−42,913→ 0 total
    Exercise: $0.09Exp: 2020-03-31→ Ordinary Shares (42,913 underlying)
  • Exercise/Conversion

    Ordinary Shares

    2017-04-21$0.09/sh+42,913$3,862→ 91,184 total
  • Exercise/Conversion

    Ordinary Shares

    2017-04-21$0.09/sh+22,371$2,013→ 113,555 total
  • Exercise/Conversion

    Ordinary Shares

    2017-04-21$0.26/sh+21,460$5,580→ 135,015 total
  • Exercise/Conversion

    Share Option (Right to Buy)

    2017-04-21−22,371→ 0 total
    Exercise: $0.09Exp: 2018-09-30→ Ordinary Shares (22,371 underlying)
  • Exercise/Conversion

    Share Option (Right to Buy)

    2017-04-21−21,460→ 0 total
    Exercise: $0.26Exp: 2021-12-31→ Ordinary Shares (21,460 underlying)
Footnotes (3)
  • [F1]Options became fully exercisable on March 31, 2014.
  • [F2]Options became fully exercisable on September 30, 2012.
  • [F3]Options became fully exercisable on December 31, 2015.

Documents

1 file

Issuer

Oxford Immunotec Global PLC

CIK 0001586049

→
Entity typeoperating
IncorporatedUnited Kingdom

Related Parties

1
  • filerCIK 0001586049

Filing Metadata

Form type
4
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 4:30 PM ET
Size
13.4 KB
View on SEC.gov